CIK 0001867096
- Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 871082097
- Phone
- +1 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- 4 Grant or award Director acquired 42,500 shares (grant or award)
- 4 Grant or award Director acquired 42,500 shares (grant or award)
- 4 Grant or award Director acquired 85,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Shannon John Patrick Jr acquired 750,000 shares (grant or award)
- 4 Grant or award Edick Paul R acquired 750,000 shares (grant or award)
- 4 Grant or award Pieper Steven acquired 750,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Hecht Beth acquired 350,000 shares (grant or award)
- 4 Grant or award JOHNSON KENNETH ERLAND acquired 100,000 shares (grant or award)
- 4 Open-market buy Edick Paul R bought 20,000 shares at $1.45 ($29,000)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Open-market buy Edick Paul R bought 100,000 shares at $1.40 ($140,380)
- 4 Open-market sale Chief Scientific Officer sold 11,228 shares at $2.42 ($27,158)
Page 7 of 9 · 178 filings